Myricetin ameliorates cognitive impairment in 3×Tg Alzheimer’s disease mice by regulating oxidative stress and tau hyperphosphorylation
Biomedicine & Pharmacotherapy,
Год журнала:
2024,
Номер
177, С. 116963 - 116963
Опубликована: Июнь 17, 2024
Alzheimer's
disease
is
characterized
by
abnormal
β-amyloid
(Aβ)
plaque
accumulation,
tau
hyperphosphorylation,
reactive
oxidative
stress,
mitochondrial
dysfunction
and
synaptic
loss.
Myricetin,
a
dietary
flavonoid,
has
been
shown
to
exert
neuroprotective
effects
in
vitro
vivo.
Here,
we
aimed
elucidate
the
mechanism
pathways
involved
protective
effect
of
myricetin.
Язык: Английский
The role of gastrodin in the management of CNS‐related diseases: Underlying mechanisms to therapeutic perspectives
Phytotherapy Research,
Год журнала:
2024,
Номер
38(11), С. 5107 - 5133
Опубликована: Авг. 15, 2024
Abstract
Central
nervous
system
(CNS)‐related
diseases
have
a
high
mortality
rate,
are
serious
threat
to
physical
and
mental
health,
always
been
an
important
area
of
research.
Gastrodin,
the
main
active
metabolite
Gastrodia
elata
Blume,
used
in
Chinese
medicine
food,
has
wide
range
pharmacological
effects,
mostly
related
CNS
disorders.
This
review
aims
systematically
summarize
discuss
effects
underlying
mechanisms
gastrodin
treatment
diseases,
assess
its
potential
for
further
development
as
lead
drug
both
biomedicine
traditional
medicine.
Studies
on
indicate
that
it
may
exert
anti‐neurodegenerative,
cerebrovascular
protective,
ameliorative
diabetic
encephalopathy,
perioperative
neurocognitive
dysfunction,
epilepsy,
Tourette's
syndrome,
depression
anxiety,
sleep
disorders
through
various
mechanisms.
To
date,
110
products
approved
clinical
use,
but
multicenter
case–control
studies
relatively
scarce.
Preclinical
confirmed
can
be
treat
CNS‐related
However,
concerns
need
addressed
context
likely
non‐specific,
assay
interfering
when
is
studied
using
vitro
silico
approaches,
calling
systematic
assessment
evidence
date.
High‐quality
trials
should
priority
evaluate
therapeutic
safety
efficacy
gastrodin.
Further
experimental
research
appropriate
vivo
models
also
needed,
focusing
neurodegenerative
cerebral
ischemic
hypoxic
brain
damage
caused
by
methamphetamine
or
heavy
metals,
epilepsy.
Язык: Английский
Gastrodin Ameliorates Tau Pathology and BBB Dysfunction in 3xTg‐AD Transgenic Mice by Regulating the ADRA1/NF‐κB/NLRP3 Pathway to Reduce Neuroinflammation
Phytotherapy Research,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 18, 2025
ABSTRACT
Background
and
aim:
Gastrodin,
an
active
compound
derived
from
the
traditional
Chinese
herbal
medicine
Gastrodia,
demonstrates
a
variety
of
pharmacological
effects,
particularly
in
enhancement
neural
functions.
Thus,
aim
this
study
is
to
explore
therapeutic
effects
gastrodin
on
Alzheimer's
disease
(AD)
its
underlying
molecular
mechanisms.
Experimental
procedure:
Cognitive
function
was
assessed
via
Morris
water
maze
Y‐maze
tests.
Tau
pathology,
neuroinflammation,
BBB
dysfunction
were
analyzed
using
various
techniques,
including
Western
blot,
immunohistochemistry,
ELISA.
ADRA1
overexpression
induced
by
lentiviral
infection,
gastrodin's
impact
NF‐κB
p65,
NLRP3,
IL‐1β,
IL‐18
levels
evaluated.
Key
results:
In
vivo
experiment,
enhanced
learning
spatial
memory
3xTg‐AD
mice,
as
well
reducing
p‐Tau
protein
expression
hippocampus
cortex.
Gastrodin
inhibited
ADRA1/NF‐κB/NLRP3
pathway,
which
decreased
glial
cell
activation
inflammatory
cytokines
IL‐1β
IL‐18,
improving
neuron
function.
vitro
NF‐κB/NLRP3
pathway
due
prevented
Aβ
42
‐induced
increase
SH‐SY5Y
cells.
It
also
reduced
cytokine
release,
restoring
tight
junction
bEnd.3
Conclusions
implications:
ameliorates
abilities
alleviating
neuroinflammation
tau
structure
neurons
BBB,
suggesting
that
may
serve
effective
drug
for
treatment
AD.
Язык: Английский
Gastrodin Alleviates Tau Pathology by Targeting the Alzheimer's Risk Gene FERMT2, Reversing the Reduction in Brain Viscoelasticity
CNS Neuroscience & Therapeutics,
Год журнала:
2025,
Номер
31(3)
Опубликована: Март 1, 2025
The
pathogenesis
of
Alzheimer's
disease
(AD)
remains
incompletely
elucidated,
and
there
is
a
notable
deficiency
in
effective
safe
therapeutic
interventions.
influence
brain
matrix
viscoelasticity
on
the
progression
AD
has
frequently
been
underestimated.
It
imperative
to
elucidate
these
overlooked
pathogenic
factors
innovate
novel
strategies
for
AD.
Gastrodin,
bioactive
constituent
derived
from
traditional
Chinese
medicinal
herb
Gastrodia
elata,
exhibits
range
pharmacological
properties,
notably
enhancement
neural
function.
Nevertheless,
underlying
mechanisms
its
action
remain
insufficiently
elucidated.
Consequently,
this
study
seeks
examine
effects
gastrodin
context
AD,
with
particular
emphasis
potential
viscoelastic
properties
matrix.
This
employs
methodologies,
including
Morris
water
maze
test,
Y-maze
spontaneous
alternation
atomic
force
microscopy
(AFM),
immunofluorescence,
transmission
electron
microscopy,
molecular
docking,
Cellular
Thermal
Shift
Assay
(CETSA),
demonstrate
that
mitigates
tau
pathology
by
modulating
FERMT2,
thereby
reversing
deterioration
mechanical
brain.
Gastrodin
administration
via
gavage
demonstrated
mitigate
cognitive
decline
associated
attenuate
hyperphosphorylation
protein
hippocampus
cortex,
ameliorate
synaptic
damage.
Additionally,
was
observed
counteract
reduction
3xTg-AD
mice,
as
evidenced
upregulation
extracellular
components
pertinent
viscoelasticity,
collagen
types
I
IV.
Furthermore,
docking
CETSA
revealed
strong
binding
affinity
between
FERMT2.
treatment
resulted
FERMT2
fluorescence
intensity,
which
selectively
expressed
astrocytes.
contributed
restoration
blood-brain
barrier
(BBB)
modulated
expression
levels
inflammatory
mediators
interleukin-6
(IL-6),
tumor
necrosis
factor-alpha
(TNF-α),
metallopeptidase
8
(MMP8).
pathology,
enhancing
learning
memory
mouse
models.
effect
may
be
mediated
through
modulation
cerebral
mechanosensor
facilitates
structure
process
potentially
linked
maintenance
BBB
integrity
factor
release.
Язык: Английский
mTOR inhibition alleviated tau phosphorylation-induced mitochondrial impairment, oxidative stress, and cognitive impairment
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Ноя. 24, 2024
Aim:
Hyperphosphorylated
tau
plays
a
crucial
role
in
the
pathogenesis
of
Alzheimer's
disease
(AD).
Whether
mammalian
target
rapamycin
(mTOR)
directly
interacts
with
Tau
protein
at
Ser214,
Ser356
and
Thr231
is
not
clear.
This
study
aimed
to
investigate
whether
mTOR-regulated
phosphorylation
disrupts
mitochondrial
dynamics
function
rapamycin,
an
mTOR
inhibitor,
can
modulate
levels
attenuate
AD-related
alterations.
Methods:
Adeno-associated
virus
(AAV)
vectors
were
used
intracranially
deliver
TauS214E/T231E/S356E
(Tau3E)
variant
into
2-month-old
C57BL/6
mice.
The
mice
intraperitoneally
administered
inhibitor
for
one
week,
followed
by
assessment
via
Morris
water
maze
test.
Western
blot
analysis,
immunofluorescence
staining,
flow
cytometry
employed
measure
expression
mTOR,
p70S6K,
tau;
dynamics;
reactive
oxygen
species
(ROS)
HT22
cells
mouse
model
overexpressing
Tau3E,
as
well
postmortem
brain
tissues
from
AD
patients.
Results:
p-mTORS2448
colocalized
p-TauSer214,
p-TauSer356,
p-TauThr231
hippocampal
CA3
region
Tau3E
presented
elevated
p-mTOR,
downstream
p-p70S6K,
ROS
production;
fragmentation;
p-TauThr231.
Rapamycin
treatment
partially
mitigated
cognitive
molecular
alterations
Conclusion:
revealed
causal
link
between
Ser356,
p-Thr231
upregulation
impairments
ROS,
dysfunction
function.
Treatment
using
(i.p.)
alleviate
impairment,
reduce
p-Tau
restore
homeostasis,
neuronal
loss
impairment
Язык: Английский
Isoliquiritigenin attenuated cognitive impairment, cerebral tau phosphorylation and oxidative stress in a streptozotocin-induced mouse model of Alzheimers disease
Zhi Tang,
Tong-Tong Sha,
Yun-sheng WANG
и другие.
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Ноя. 28, 2024
Introduction
Tau
hyperphosphorylation,
mitochondrial
dysfunction
and
oxidative
stress
play
important
roles
in
Alzheimer′s
disease
(AD).
Isoliquiritigenin,
a
natural
flavonoid
isolated
from
the
root
of
liquorice,
has
been
shown
to
exert
inhibitory
effects
on
stress.
Here,
we
assessed
neuroprotective
isoliquiritigenin
streptozotocin-injected
mouse
model.
Method
Molecular
docking
analysis
performed
for
with
mTOR
ERK2.
The
mice
(n
=
27,
male)
were
intracerebroventricularly
injected
streptozotocin,
treated
(intraperitoneal,
2
days)
using
Morris
water
maze.
Oxidative
stress,
tau
phosphorylation,
synaptic
impairment
evaluated
cortex
hippocampal
tissues
by
biochemical
assays
immunofluorescence
staining.
Results
Isoliquiritigenin
treatment
mitigated
spatial
memory
capacity
alleviated
phosphorylation
at
Ser396;
production
reactive
oxygen
species;
fission
proteins
Mfn1
Mfn2;
neuronal
loss;
(PSD95,
SNAP25).
reduced
levels
Ser2448
ERK1/2
T202/Y204
upregulated
level
GSK-3βSer9
hippocampus
mice.
Conclusion
In
conclusion,
our
findings
suggest
that
ameliorates
streptozotocin-induced
cognitive
impairment,
hyperphosphorylated
tau,
decreasing
ERK
activity
increasing
GSK-3β
activity.
Язык: Английский